Pattern of failure in endometrial cancer patients;Analiza czynników ryzyka nawrotu po leczeniu raka błony śluzowej trzonu macicy

Ginekologia Polska

Volumn 80, Issue 9, 2009, Pages 687-693

  Kamil, Zalewski ^a   Jakub, Rzepka ^a   Radosław, Madry ^b   Anna, Dańska Bidzińska ^a   Mariusz, Bidzinski ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b Oddzia Ginekologii Kliniki Onkologii Uniwersytetu Medycznego w Poznaniu   (Poland)

Author keywords

Duty to recontact; Endometrial neoplasms; Recurrence

Indexed keywords

EID: 77952588110     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. http://www.csioz.gov.pl
2. Morrow C, Bundy B, Kurman R, [et al.]. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991, 40, 55-65.
3. Tjalma W, van Dam P, Makar A, [et al.]. The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients. Int J Gynecol Cancer. 2004, 14, 931-947.
4. Morice P, Levy-Piedbois C, Ajaj S, [et al.]. Value and post evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer. Eur J Cancer. 2001, 37, 985-990.
5. Owen P, Duncan I. Is there any value in the long term follow up of women treated for endometrial cancer? Br J Obstet Gynaecol. 1996, 103, 710-713.
6. Gordon A, Owen P, Chien P, [et al.]. A critical evaluation of follow-up of women treated for endometrial adenocarcinoma. J Obstet Gynaecol. 1997, 17, 386-389.
7. Salvesen H, Akslen L, Iversen T, [et al.]. Recurrence of endometrial carcinoma and the value of routine follow up. Br J Obstet Gynaecol. 1997, 104, 1302-1307.
8. Shumsky A, Stuart G, Brasher P, [et al.]. An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol. 1994, 55, 229-233.
9. Podczaski E, Kaminski P, Gurski K, [et al.]. Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery. Gynecol Oncol. 1992, 4, :323-327.
10. MacDonald J, Kidd G. An audit of endometrial carcinoma: the value of routine follow up. J Obstet Gynaecol. 1990, 10, 548-550.
11. Gadducci A, Cosio S, Fanucchi A, [et al.]. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Anticancer Res. 2000, 20, 1977-1984.
12. Agboola O, Grunfeld E, Coyle D, [et al.]. Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ. 1997, 157, 879-886.
13. Berchuck A, Anspach C, Evans A, [et al.]. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol. 1995, 59, 20-24.
14. Tjama W, Van Dam P, Makar A, [et al.]. The clinical value and costeffctivness of follow-up in endometrial cancer patients. Int J Gynecol Cancer. 2004, 14, 931-937.
15. Aalders J, Abeler V, and Kolstad P. Recurrent adenocarcinoma of the endometrium: A clinical and histopathological study of 379 patients. Gynecol Oncol. 1984, 17, 85-103.
16. Burke T, Heller P, Woodward J, [et al.]. Treatment failure in endometrial carcinoma. Obstet Gynecol. 1990, 75, 96-101.
17. DiSaia P, Creasman W, Boronow R, [et al.]. Risk factors and recurrent patterns in stage I endometrial cancer. Am J Obstet Gynecol. 1985, 151, 1009-1015.
18. Reddoch J, Burke T, Morris M, [et al.]. Surveillance for Recurrent Endometrial Carcinoma: Development of a Follow-up Scheme. Gynecol Oncol. 1995, 59, 221-225.
19. Lurain J, Rice B, Rademaker A, [et al.]. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol. 1991, 78, 63-69.
20. Hacker N. Uterine cancer. In Practical gynecologic oncology. 2nd edition. Ed. Berek J, Hacker N. Philadelphia: Williams & Wilkins, 1994, 285-327.
21. Creasman W, Morrow C, Bundy B, [et al.]. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer. 1987, 60, 2035-2041.
22. Rosenberg P, Blom R, Hogberg T, [et al.]. Death rate and recurrence pattern among 841 clinical stage I endometrial cancer pripatients with special reference to uterine papillary serous carcinoma. Gynecol Oncol. 1993, 51, 311-315.
23. Łapińska-Szumczyk S, Emerich J, De{ogonek}bniak J. Ryzyko wznowy procesu nowotworowego wśród chorych na raka błony śluzowej trzonu macicy. Ginekol Pol. 2005, 76, 108-114.
24. Tjama W, Van Dam P, Makar A, [et al.]. The clinical value and cost-effctivness of follow-up in endometrial cancer patients. Int J Gynecol Cancer. 2004, 14, 931-937.
25. Grunfeld E, Levine M, Julian J, [et al.]. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006, 24, 835-848-855.
26. Otsuka I, Ono I, Akamatsu H, [et al.]. Pulmonary metastasis from endometrial carcinoma. Int J Gynecol Cancer. 2002, 12, 208-213.
27. Olaitan A, Murdoch J, Anderson R, [et al.]. A critical evaluation of current protocols for the follow-up of women treated for gynecological malignancies: a pilot study. Int J Gynecol Cancer. 2001, 11, 349-353.